Prognia

Ward

Suture

Osler

Create your free account

Loading…

prognia.

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

For organisations

Hospitals
Universities and medical schools
Pharmaceutical companies

Loading…

Zenodo

Plasma p-tau217 prescreening for Alzheimer's disease trials – R code

19 October 2026Original research1 min read

By Pâmela C.L. Ferreira, Guilherme Povala and Tharick Ali Pascoal.

Read the original

On this page

Abstract
Keywords
Authors
Source

Abstract

R code of the data analysis for the paper "Plasma p-tau217 thresholds streamline recruitment for Alzheimer's disease clinical trials". # ContactIf you have any questions or suggestions, please feel free to contact the corresponding author.

Keywords

Dementia and Cognitive Impairment Research
phosphorylated tau217

Read around a topic while you study.

Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.

Discover Ward

plasma biomarkers

Alzheimer's disease

trial recruitment

biomarker thresholds

Open access

Authors

Pâmela C.L. Ferreira
Guilherme Povala
Tharick Ali Pascoal

Source

Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.

doi.org/10.5281/zenodo.23483018

Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.

At a glance

Journal: Zenodo
Type: Original research
Published: 19 October 2026
Specialty: Neurology
Read time: 1 min
Authors: 3
DOI: 10.5281/zenodo.23483018